| Racial and Ethnic Disparities in Medication Adherence Among Privately Insured Patients in the United States Z Xie, PS Clair, DP Goldman, G Joyce PloS one 14 (2), 2019 | 116 | 2019 |
| Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities KE Van Nuys, Z Xie, B Tysinger, MA Hlatky, DP Goldman JACC: Heart Failure 6 (5), 401-409, 2018 | 56 | 2018 |
| Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States RZ Xie, EF Malik, MT Linthicum, JL Bright PharmacoEconomics, 1-8, 2021 | 30 | 2021 |
| Extended-Release Formulation and Medication Adherence JA Romley, Z Xie, T Chiou, D Goldman, AL Peters Journal of General Internal Medicine 35 (1), 354-356, 2020 | 11 | 2020 |
| Should we pay for scientific knowledge spillovers? The underappreciated value of “failed” R&D efforts RZ Xie, A Towse, LP Garrison International Journal of Technology Assessment in Health Care 38 (1), e31, 2022 | 8 | 2022 |
| Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience S DosReis, LM Bozzi, B Butler, RZ Xie, RH Chapman, J Bright, E Malik, ... The Patient-Patient-Centered Outcomes Research 16 (1), 57-66, 2023 | 5 | 2023 |
| Patient perspectives: an integral part of health technology assessment methodology J Spangler, T Huth, R Xie International Journal of Technology Assessment in Health Care 38 (1), e85, 2022 | 4 | 2022 |
| Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States LN Pizzicato, RZ Xie, Y Yang, M Grabner, RH Chapman Journal of Managed Care & Specialty Pharmacy 29 (6), 614-625, 2023 | 2 | 2023 |
| Advancing methods to measure and reward healthcare innovation R Chapman, R Xie PharmacoEconomics 42 (Suppl 2), 183-185, 2024 | 1 | 2024 |
| HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable R Xie, MY Cheng, J Bright, J Spangler, JL Krieger, M Graglia, R Chapman Value in Health 26 (6), S273, 2023 | 1 | 2023 |
| The Impact of the Inflation Reduction Act on Investment in Innovative Medicines: A Project-Level Analysis RZ Xie, T Cameron, P Kolchinsky | | 2024 |
| HPR171 Estimating the Impacts of Government-Mandated Price Reductions on Indication Expansion for Launched Drugs: A Real-World Study J Rhuda, R Xie, T Cameron, P Kolchinsky Value in Health 27 (12), S308, 2024 | | 2024 |
| Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis JF Slejko, TJ Mattingly II, A Wilson, R Xie, RH Chapman, A Amill-Rosario Value in Health, 2024 | | 2024 |
| EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model R Chapman, M Cheng, R Xie Value in Health 27 (6), S149, 2024 | | 2024 |
| HTA296 Applying Continual Stakeholder Engagement to Develop Multi-Criteria Decision Analysis (MCDA) for Health Technology Assessment in Major Depressive Disorder (MDD) R Chapman, R Xie, YYM Cheng, CE Phelps, K Marsh, P Thokala Value in Health 26 (12), S377-S378, 2023 | | 2023 |
| Principles to Understanding Economic Impacts on Patients and Caregivers E Malik, J Bright, E Cope, G Darien, M Edmunds, M Ridley, R Xie, ... 2023 Annual Research Meeting, 2023 | | 2023 |
| PCR195 Developing a Framework to Capture Economic Impacts on Patients and Caregivers: Recommendations to Guide Patient-Centered Outcomes Research and Value Assessment E Malik, R Xie, J Bright, R Chapman, E Cope, M Edmunds Value in Health 26 (6), S348, 2023 | | 2023 |
| PCR113 Treatment Preferences Among Adults with Reduced Productivity Due to Depression A Amill-Rosario, JF Slejko, R Xie, R Chapman Value in Health 26 (6), S332, 2023 | | 2023 |
| EE248 Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis JF Slejko, TJ Mattingly, A Wilson, R Xie, R Chapman Value in Health 26 (6), S104, 2023 | | 2023 |
| EE133 Applying Stakeholder Engagement to Effectively Design User Interfaces for an Economic Model in Major Depressive Disorder MY Cheng, R Xie, E Malik, M Mersky, R Chapman Value in Health 26 (6), S83-S84, 2023 | | 2023 |
Dana P GoldmanSol Price School of Public Policy, University of Southern California在 usc.edu 的电子邮件经过验证
